SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-105381
Filing Date
2023-09-29
Accepted
2023-09-29 17:00:13
Documents
12
Period of Report
2023-09-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327211d1_8k.htm   iXBRL 8-K 25198
  Complete submission text file 0001104659-23-105381.txt   196171

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20230925.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20230925_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20230925_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2327211d1_8k_htm.xml XML 3210
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 231296451
SIC: 2834 Pharmaceutical Preparations